Literature DB >> 20838362

Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area.

Noel T Brewer1, Sami L Gottlieb, Paul L Reiter, Annie-Laurie McRee, Nicole Liddon, Lauri Markowitz, Jennifer S Smith.   

Abstract

BACKGROUND: Human papillomavirus (HPV) vaccine uptake is low among adolescent girls in the United States. We sought to identify longitudinal predictors of HPV vaccine initiation in populations at elevated risk for cervical cancer.
METHODS: We interviewed a population-based sample of parents of 10- to 18-year-old girls in areas of North Carolina with elevated cervical cancer rates. Baseline interviews occurred in summer 2007 and follow-up interviews in fall 2008. Measures included health belief model constructs.
RESULTS: Parents reported that 27% (149/567) of their daughters had initiated HPV vaccine between baseline and follow-up. Of parents who at baseline intended to get their daughters the vaccine in the next year, only 38% (126/348) had done so by follow-up. Of parents of daughters who remained unvaccinated at follow-up but had seen a doctor since baseline, only 37% (122/388) received an HPV vaccine recommendation. Rates of HPV vaccine initiation were higher among parents who at baseline perceived lower barriers to getting HPV vaccine, anticipated greater regret if their daughters got HPV because they were unvaccinated, did not report "needing more information" as the main reason they had not already vaccinated, intended to get their daughters the vaccine, or were not born-again Christians.
CONCLUSIONS: Missed opportunities to increase HPV vaccine uptake included unrealized parent intentions and absent doctor recommendations. While several health belief model constructs identified in early acceptability studies (e.g., perceived risk, perceived vaccine effectiveness) were not longitudinally associated with HPV vaccine initiation, our findings suggest correlates of uptake (e.g., anticipated regret) that offer novel opportunities for intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20838362      PMCID: PMC3025264          DOI: 10.1097/OLQ.0b013e3181f12dbf

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  25 in total

1.  Viral sexually transmitted disease vaccine acceptability among college students.

Authors:  Constance W Boehner; Steven R Howe; David I Bernstein; Susan L Rosenthal
Journal:  Sex Transm Dis       Date:  2003-10       Impact factor: 2.830

2.  Maximizing the potential public health impact of HPV vaccines: a focus on parents.

Authors:  Jessica A Kahn
Journal:  J Adolesc Health       Date:  2007-02       Impact factor: 5.012

3.  Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis.

Authors:  Norman A Constantine; Petra Jerman
Journal:  J Adolesc Health       Date:  2006-12-06       Impact factor: 5.012

Review 4.  Chapter 24: Psychosocial aspects of vaccine acceptability.

Authors:  Gregory D Zimet; Nicole Liddon; Susan L Rosenthal; Eduardo Lazcano-Ponce; Betania Allen
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

5.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

6.  Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata.

Authors:  Richard Kent Zimmerman; Mahlon Raymund; Janine E Janosky; Mary Patricia Nowalk; Michael J Fine
Journal:  Vaccine       Date:  2003-03-28       Impact factor: 3.641

7.  The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate.

Authors:  Annie-Laurie McRee; Noel T Brewer; Paul L Reiter; Sami L Gottlieb; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2010-04       Impact factor: 2.830

8.  Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Karen R Broder; Margaret M Cortese; John K Iskander; Katrina Kretsinger; Barbara A Slade; Kristin H Brown; Christina M Mijalski; Tejpratap Tiwari; Emily J Weston; Amanda C Cohn; Pamela U Srivastava; John S Moran; Benjamin Schwartz; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-03-24

9.  Risk perceptions and their relation to risk behavior.

Authors:  Noel T Brewer; Neil D Weinstein; Cara L Cuite; James E Herrington
Journal:  Ann Behav Med       Date:  2004-04

10.  High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

Authors:  L L Villa; R L R Costa; C A Petta; R P Andrade; J Paavonen; O-E Iversen; S-E Olsson; J Høye; M Steinwall; G Riis-Johannessen; A Andersson-Ellstrom; K Elfgren; G von Krogh; M Lehtinen; C Malm; G M Tamms; K Giacoletti; L Lupinacci; R Railkar; F J Taddeo; J Bryan; M T Esser; H L Sings; A J Saah; E Barr
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

View more
  130 in total

1.  Human Papillomavirus Vaccination Among Young Adult Gay and Bisexual Men in the United States.

Authors:  Paul L Reiter; Annie-Laurie McRee; Mira L Katz; Electra D Paskett
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination.

Authors:  Laura M Kester; Gregory D Zimet; J Dennis Fortenberry; Jessica A Kahn; Marcia L Shew
Journal:  Matern Child Health J       Date:  2013-07

3.  Physicians' current use and preferences for male HPV vaccine-related patient education materials.

Authors:  Monica L Kasting; Paige Lake; Susan T Vadaparampil
Journal:  Vaccine       Date:  2017-04-09       Impact factor: 3.641

4.  Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis.

Authors:  Jennifer C Spencer; William A Calo; Noel T Brewer
Journal:  Prev Med       Date:  2019-03-29       Impact factor: 4.018

5.  Correlates of Human Papillomavirus Vaccination and Association with HPV-16 and HPV-18 DNA Detection in Young Women.

Authors:  Molly A Feder; Shalini L Kulasingam; Nancy B Kiviat; Constance Mao; Erik J Nelson; Rachel L Winer; Hilary K Whitham; John Lin; Stephen E Hawes
Journal:  J Womens Health (Larchmt)       Date:  2019-07-02       Impact factor: 2.681

6.  Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines.

Authors:  Lisa M Gargano; Natasha L Herbert; Julia E Painter; Jessica M Sales; Christopher Morfaw; Kimberly Rask; Dennis Murray; Ralph J DiClemente; James M Hughes
Journal:  Hum Vaccin Immunother       Date:  2013-07-24       Impact factor: 3.452

7.  Focusing on flu: adolescents' perspectives on school-located immunization programs for influenza vaccine.

Authors:  Mary B Short; Amy B Middleman
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

8.  Do correlates of HPV vaccine initiation differ between adolescent boys and girls?

Authors:  Melissa B Gilkey; Jennifer L Moss; Annie-Laurie McRee; Noel T Brewer
Journal:  Vaccine       Date:  2012-07-27       Impact factor: 3.641

9.  Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial.

Authors:  Noel T Brewer; Megan E Hall; Teri L Malo; Melissa B Gilkey; Beth Quinn; Christine Lathren
Journal:  Pediatrics       Date:  2016-12-05       Impact factor: 7.124

10.  Quality of physician communication about human papillomavirus vaccine: findings from a national survey.

Authors:  Melissa B Gilkey; Teri L Malo; Parth D Shah; Megan E Hall; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.